Don’t miss the latest developments in business and finance.

GPT Healthcare rises on debut

Image
Last Updated : Feb 29 2024 | 11:04 AM IST

Shares of GPT Healthcare were currently trading at Rs 202.70 at 10:49 IST on the BSE, representing a premium of 8.98% as compared with the issue price of Rs 186.

The scrip was listed at Rs 216.15, exhibiting a premium of 16.21% to the issue price.

So far, the stock has hit a high of 219.70and a low of 200.20. On the BSE, over 7.02 lakh shares of the company were traded in the counter so far.

The initial public offer (IPO) of GPT Healthcare was subscribed 8.52 times. The issue opened for bidding on 22 February 2024 and it closed on 26 February 2024. The price band of the IPO was fixed at Rs 177 to 186 per share.

The offer comprised of fresh issue of equity shares aggregating up to Rs 40 crore and offer for sale of 26,082,786 equity shares aggregating up to Rs 485.14 crore.

The promoters and and promoter group held 67.34% of the pre-offer issued and paid-up equity share capital. The post IPO shareholding for the same is expected to be around 65.57%.

More From This Section

The objectives for the fresh issue includes Rs 30 crore for repayment/prepayment of certain borrowings and the remaining amount is to be used for general corporate purposes.

GPT Healthcare operates a chain of mid-sized full-service hospitals under the same brand and provides integrated healthcare services, with a focus on secondary and tertiary care. As of 30 September 2023, the company operated four multispecialty hospitals in Dum Dum, salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds.

The company offers comprehensive range of healthcare services across over 35 specialties and superspecialties including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general suregery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology.

The firm reported a net profit of Rs 23.49 crore and sales of Rs 204.18 crore for the six months ended on 30 September 2023.

Powered by Capital Market - Live News

Also Read

First Published: Feb 29 2024 | 10:54 AM IST

Next Story